Table 1 Baseline characteristics of study participants stratified by COVID-19 status
From: Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19
| Non COVID-19 (n = 72) | COVID-19 (n = 28) | |
|---|---|---|
| Female (N, %) | 59 (81.9) | 25 (89.3) |
| Male (N, %) | 13 (18.1) | 3 (10.7) |
| Age group 18–35 years (N, %) | 20 (27.7) | 13 (46.4) |
| Age group 36–50 years (N, %) | 28 (38.9) | 9 (32.14) |
| Age group 51–65 years (N, %) | 24 (33.3) | 6 (21.4) |
| Respiratory symptoms (N, %) | 17 (60.7) | |
| Neurological symptoms (N, %) | 21 (75.0) |